Advertisement
Screener

CHINA PHARMA HOLDINGS, INC. (CPHI) Finite-Lived Intangible Asset, Expected Amortization, Year Two

2.8 / 5 stars · 68/120 Roast Me

CHINA PHARMA HOLDINGS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year Two

CHINA PHARMA HOLDINGS, INC. (CPHI) had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $2.38 million as of 2025-12-31, per its 10-K filed 2026-04-01.

Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2026-04-01

  • 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $2.38M.
  • 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $497.61K.
  • 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $321.24K.
  • 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $211.94K.
Period endFinite-Lived Intangible Asset, Expected Amortization, Year Two
2025-12-31$2.38M
10-K · filed 2026-04-01
2024-12-31$497.61K
10-K · filed 2025-03-31
2023-12-31$321.24K
10-K · filed 2024-04-01
2022-12-31$211.94K
10-K · filed 2023-03-30
2020-12-31$37.69K
10-K · filed 2021-03-26
2019-12-31$35.25K
10-K · filed 2020-03-30
2018-12-31$37.11K
10-K · filed 2019-03-28
2017-12-31$61.14K
10-K · filed 2018-04-02
2016-12-31$109.87K
10-K · filed 2017-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30